ImmuneBridge

Seed
immunebridge.com Biotech & Healthcare San Francisco, United States
Total Funding $7.7M
Latest Round $7.7M Seed
Last Announced Mar 24, 2026
Investors Undisclosed
Decision Makers 6 Verified

About ImmuneBridge

ImmuneBridge is developing allogeneic immunotherapies for cancer.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters San Francisco, United States
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website immunebridge.com
Domain Registered Date Jul 20, 2015

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $7,700,000 · Seed

    fundraisingfox.com

  2. Milestone

    Website domain registered

    immunebridge.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for ImmuneBridge.

Funding History

1 Round
Seed · Mar 24, 2026

Founders & Leadership

2

Jesse Cotari

Founder

Work email & phone locked Unlock →

Peretz Partensky

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts